Navigation Links
Novocure™ to Present NovoTTF™ Therapy Data at the 2012 Annual Scientific Meeting of the American Society of Clinical Oncology
Date:5/29/2012

f Research and Development, Novocure Inc.
Dr. Angela Davies, Chief Medical Officer, Novocure Inc.
Date/Time:  Sunday, June 3, 11:30 am – 12:30 pm
Location: ASCO Oncology Professional Hall

Novocure will unveil its ongoing pivotal phase III study, EF14, in newly diagnosed glioblastoma, discussing trial design and rationale at a poster session.  The EF14 study is aimed at establishing NovoTTF therapy in the front line setting with current standard of care and is a follow-up to the successful phase III study, EF11, of NovoTTF monotherapy in recurrent glioblastoma.

  • Ongoing trials: Phase 3 Trial of Tumor Treating Fields (TTFields) together with temozolomide compared to temozolomide (TMZ) alone in Patients with Newly Diagnosed Glioblastoma Multiforme

Presenter:  Dr. Santosh Kesari, University of California, San Diego
Date/Time:  Saturday, June 2, 1:15 pm – 5:15 pm
Session:  Poster, S Hall A2
Abstract #TPS2106

Several clinical trial and experimental data updates will also be published in conjunction with ASCO 2012 and can be found online at http://abstract.asco.org/:

Principal Author:  Dr. Miklos Pless, Kantonsspital, Winterthur, Switzerland
Publication number:  e18012

Principal Author:  Sz
'/>"/>

SOURCE Novocure
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. Lexicon to Present Research Results at American Chemical Society Meeting Regarding Target of LX1031 Drug Candidate
3. Genaera Corporation Presents Interim Phase 1 Data for Obesity Compound Trodusquemine (MSI-1436) at IBC Conference
4. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
5. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
6. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
7. Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference
8. Iomai Announces Data from Phase 2 Field Study of Travelers Diarrhea Vaccine Accepted for Presentation at ICAAC
9. Poniard Pharmaceuticals to Present Updated Results of Picoplatin Phase 2 Small Cell Lung Cancer Trial at 12th World Conference on Lung Cancer
10. New Study Presented at WorldSleep 2007 Demonstrates Ramelteon Has Sustained Efficacy Over Six Months in Adults With Chronic Insomnia
11. ViroPharma to Present at Three Upcoming Healthcare Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... The global mHealth market ... by 2020, growing at a CAGR of 47.6% from ... Grand View Research, Inc. Monitoring services is expected to ... to 2020.      (Logo: http://photos.prnewswire.com/prnh/20150105/723757 ) ... incidences of chronic diseases such as cancer, heart ailments, ...
(Date:8/27/2015)... 27, 2015 DURECT Corporation (Nasdaq: DRRX ... at three upcoming healthcare conferences.  , ... present at the Rodman & Renshaw Investment Conference on ... conference is being held at the St. Regis Hotel ... live audio webcast of the presentation will be available ...
(Date:8/27/2015)... India , August 27, 2015 According ... Product (Transfer, Hammock, Toilet, Seating, Universal, Standing, Bariatric ), Material (Nylon, ... - Forecast to 2020", published by MarketsandMarkets, the Medical Lifting Sling ... USD 411.5 Million in 2015, at a CAGR of 11.4 % ... 136 ma rket data T ables and ...
Breaking Medicine Technology:mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 2mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 3mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 4mHealth Market is Expected to Reach $49.12 Billion By 2020: Grand View Research, Inc. 5DURECT to Participate in Upcoming Healthcare Conferences 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 2Medical Lifting Sling Market Worth USD 706.0 Million by 2020 3Medical Lifting Sling Market Worth USD 706.0 Million by 2020 4
... Pharmaceuticals, Inc. (Nasdaq: ALXA ), today announced that ... warrants to purchase shares of its common stock in an ... sole book-running manager in the offering. The ... no assurance as to whether or when the offering may ...
... Wash., Feb. 16, 2012  SCOLR Pharma, Inc. (OTCQB: SCLR) ... nutritional/vitamin products based on the Company,s patented oral drug delivery ... Eleven class-leading products are now being sold under various ... top retail chains.  Each product has ...
Cached Medicine Technology:Alexza Announces Proposed Public Offering of Common Stock and Warrants 2Alexza Announces Proposed Public Offering of Common Stock and Warrants 3Alexza Announces Proposed Public Offering of Common Stock and Warrants 4SCOLR Pharma, Inc. Launches Cutting Edge Nutritional Products at Major Retailers in 2012 2
(Date:8/29/2015)... ... 29, 2015 , ... The popular television program VOICES IN AMERICA, hosted by ... will be devoting an entire short segment to the subject of diabetes. Diabetes is ... on a daily basis, but recent advancements in medical science may prove to be ...
(Date:8/28/2015)... ... 29, 2015 , ... Rio Salado College joined nine educational institutions ... part of the EDUCAUSE - Next Generation Learning Challenges 2015 Breakthrough Models Incubator funded ... Breakthrough Models Incubator hosted by EDUCAUSE and NGLC, which is designed to ...
(Date:8/28/2015)... ... , ... An online provider of CPAP machines, masks, supplies, and accessories, My ... affordable by offering shipping at no cost to you, directly to your door on ... size. My Cpap Store is located in Las Vegas, Nevada. , Sleep apnea is ...
(Date:8/28/2015)... , ... August 28, 2015 , ... The Kentucky State ... are qualified for the position they are applying for, they are unable to pass ... employers are considering altering drug testing policies in order to be able to hire ...
(Date:8/28/2015)... ... 2015 , ... With the goal of furthering music education programs in schools, ... Adams County Fairgrounds in Mendon, IL on May 30th, 2015. Backed once again by ... in the underfunded school districts of Mendon and its neighboring town of Quincy, IL. ...
Breaking Medicine News(10 mins):Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 2Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 3Health News:Rio Salado College Joins 9 Educational Leaders to Reinvent Higher Learning 4Health News:My Cpap Store Now Offering Delivery Special 0 Cost to You 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 2Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 3Health News:Hiring Obstacles: Drug Abuse a Problem for Workforce 4Health News:Best Drug Rehabilitation Interviews Country-Rock Duo Highway Run at the 2015 "Music With A Mission" Benefit Concert 2
... The Jewish Home has named Nitin Nanda, M.D., ... Dr. Nanda will also serve as medical director of ... the Home,s Joyce Eisenberg-Keefer Medical Center on the Grancell ... positions, Dr. Nanda will be responsible for the supervision ...
... of Georgia is part of a large national study ... 10,000 healthy individuals in an effort to pinpoint variations ... samples taken from each group will enable a sophisticated ... convey individual risk for the disease that affects about ...
... Md., April 27 Patients with stone disease could ... University of California, San Francisco suggests that ... may be sufficient to inhibit the development of calcium ... Scientific Meeting of the American Urological Association (AUA). Increased ...
... nurses and doctors utilizing expert Geriatric Doctors, the Assistant Director of ... save the medical industry potentially, $200 Billion annually. , ... ... announces a tremendous saving in lives and medical costs of ...
... 27 Estill Medical Technologies, Inc., the industry leader ... the expansion of its Thermal Angel sales and marketing ... by quickly controlling core body temperature and infection risk. ... In emergency medicine, the golden hour refers to the ...
... drugstore.com , inc. (Nasdaq: DSCM ... and pharmacy products, today announced that they have reached ... sales and use taxes owed by the Company for ... )The Company has paid an aggregate of approximately $1.7 ...
Cached Medicine News:Health News:New Chief of Geriatric Psychiatry and Behavioral Health is Announced 2Health News:MCG participating in national study to identify genetic variants in schizophrenia 2Health News:MCG participating in national study to identify genetic variants in schizophrenia 3Health News:Drinking Diet Soda May Reduce the Risk of Forming Kidney Stones 2Health News:Medical Nurse Training, Inc. Announces New Techniques to Achieve Tremendous Savings of Lives and Medical Costs of Over $200 Billion Annually 2Health News:Thermal Angel Supports Infection Control During the Golden Hour 2Health News:drugstore.com, inc. Resolves New Jersey Sales and Use Tax Case 2
... designed with the proper sensitivity and specificity ... of autoimmune disease. Sera from over 2,000 ... individuals were tested during the development of ... compared the results to reference methods such ...
... functional human C1q coated in the solid phase ... stage, CIC in the diluted patient samples and ... into the C1q coated assay wells. After incubation, ... and a ready to use conjugate (goat anti-human ...
... are formed as a host defense against ... phagocytosis. If not cleared, CIC may be ... CIC are increased in Systemic Lupus Erythematosus ... involved in other autoimmune disorders as well ...
The K-ASSAY® D-Dimer Control set is intended to be used a consistent test sample of known concentration for monitoring the performance of D-Dimer immunoturbidimetric assays....
Medicine Products: